Using the best available data to estimate the cost of antimicrobial resistance: a systematic review.

ABSTRACT:

Background

Valuation of the economic cost of antimicrobial resistance (AMR) is important for decision making and should be estimated accurately. Highly variable or erroneous estimates may alarm policy makers and hospital administrators to act, but they also create confusion as to what the most reliable estimates are and how these should be assessed. This study aimed to assess the quality of methods used in studies that quantify the costs of AMR and to determine the best available evidence of the incremental cost of these infections.

Methods

In this systematic review, we searched PubMed, Embase, Cinahl, Cochrane databases and grey literature sources published between January 2012 and October 2016. Articles reporting the additional burden of Enterococcus spp., Escher

SUBMITTER: Wozniak TM 

PROVIDER: S-EPMC6359818 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature